title: The excessive use of inhaled corticosteroids in chronic obstructive pulmonary disease.
abstract: Despite the fact that the recommendations of the main clinical guidelines have restricted the indications for inhaled corticosteroids in chronic obstructive pulmonary disease (COPD), currently more than 80% of patients are receiving this treatment in Spain, mostly with high doses. A detailed review of the literature does not justify the use of these high doses, a position that agrees with the recommendations of the FDA. A re-evaluation of their safety, the consistency of the data on their efficacy showing similar results with moderate doses and a better patient selection require the use of this treatment in COPD patients to be reconsidered.
authors.affiliation: Servicio de Neumología, Hospital Universitario de Guadalajara, España. jlizquierdo@sescam.org
authors.forename: José Luis
authors.initials: JL
authors.lastname: Izquierdo Alonso
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Rodríguez Glez-Moro
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D061214:Patient Safety; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones